ArrayExpress Uploader02537P18non-progressorNonelongitudinal time 1P18non-progressorNonelongitudinal time 2P92progressorFCRat relapseP92progressornot specifiedbefore treatmentP11progressorFCRat relapseP11progressornot specifiedbefore treatmentP71non-progressorNonelongitudinal time 2P71non-progressorNonelongitudinal time 1P82non-progressorNonelongitudinal time 2P82non-progressorNonelongitudinal time 1P19non-progressorNonelongitudinal time 2P19non-progressorNonelongitudinal time 1P30non-progressorNonelongitudinal time 2P30non-progressorNonelongitudinal time 1P94progressorFRat relapseP94progressornot specifiedbefore treatmentP93progressorFRat relapseP93progressornot specifiedbefore treatmentP95progressorFRat relapseP95progressornot specifiedbefore treatmentP6progressorFR, Chlor.at relapseP6progressornot specifiedbefore treatmentP20progressorFR, Cam+Rat relapseP20progressornot specifiedbefore treatmentP66progressorFR, Chlor.at relapseP66progressorFR, Chlor.at relapseP66progressorFR, Chlor.at relapseP66progressornot specifiedbefore treatmentP65progressorCam+Rat relapseP65progressorCam+Rat relapseP65progressornot specifiedbefore treatmentP40progressorFCR, Cam+Rat relapseP40progressornot specifiedbefore treatmentP39progressorFRat relapseP39progressornot specifiedbefore treatmentP14progressorFRat relapseP14progressorFRat relapseP14progressornot specifiedbefore treatmentP88progressorFCR, Cam+Rat relapseP88progressornot specifiedbefore treatmentarrayexpress_sid4As part of a large genetic evolution study we also acquired 3'UTR expression arrays at two time points for the same 18 patients with CLL....23415222E-GEOD-37168/profile/8773/arrayexpressuploader440cllDec.12, 2014Falseexpression-data-from-chronic-lymphocytic-leukemiaE-GEOD-37168_A-AFFY-44Expression data from chronic lymphocytic leukemia (CLL) tumors in two time pointsJul.12, 2014As part of a large genetic evolution study we also acquired 3'UTR expression arrays at two time points for the same 18 patients with CLL. We have analysed the data to evaluate whether genetic evolution (somatic mutations and Somatic copy number alterations) also manifested at the transcriptome level, either globally, or at the level of pre-defined curated geneset that correspond to specfic evolving genetic lesions. Samples were collected at two time points along the patients clinical course, with 13 patients having samples before treatment and at relapse, and 5 patients that were long term non progressors had sampling at two time points without intevening therapy.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-37168humanhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-37168/samples/